The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma

OBJECTIVE: The aim of this study was to evaluate the feasibility and efficacy of percutaneous laser ablation (PLA) for patients with multifocal papillary thyroid microcarcinoma (PTMC). MATERIALS AND METHODS: A cohort of patients who underwent ultrasound (US)-guided PLA for primary PTMC were enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lu, Zhang, Gui Ping, Zhan, Wei Wei, Zhou, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428260/
https://www.ncbi.nlm.nih.gov/pubmed/36060950
http://dx.doi.org/10.3389/fendo.2022.921812
_version_ 1784779074605940736
author Zhang, Lu
Zhang, Gui Ping
Zhan, Wei Wei
Zhou, Wei
author_facet Zhang, Lu
Zhang, Gui Ping
Zhan, Wei Wei
Zhou, Wei
author_sort Zhang, Lu
collection PubMed
description OBJECTIVE: The aim of this study was to evaluate the feasibility and efficacy of percutaneous laser ablation (PLA) for patients with multifocal papillary thyroid microcarcinoma (PTMC). MATERIALS AND METHODS: A cohort of patients who underwent ultrasound (US)-guided PLA for primary PTMC were enrolled in this study. The patients were divided into a multifocal PTMC (multi-PTMC) group and a unifocal PTMC (uni-PTMC) group. Before PLA, conventional US and contrast-enhanced ultrasound (CEUS) were performed to evaluate the PTMC and cervical lymph nodes. The operation time, energy, power, amount of isolation liquid, and complications during PLA were recorded. Patients were followed up at 2 days, 1 month, 3 months, and 6 months, and every 6 months after that. Volume reduction rate (VRR), local tumor recurrence, and lymph node metastasis after PLA were observed. RESULTS: The study included 12 patients with 26 PTMCs and 60 patients with 60 PTMCs. The operation time, total energy, and amount of isolation liquid in the multi-PTMC group were more than those in the uni-PTMC group (p = 0.000, 0.007, and 0.020, respectively). The mean follow-up durations in multi-PTMC and uni-PTMC groups were 19.75 ± 11.46 months (6–36 months) and 16.33 ± 10.01 months (4–40 months), with a similar VRR of the ablated lesions in the two groups. One and three cases with newly developed PTMCs were observed in the multi-PTMC group and the uni-PTMC group during follow-up, respectively. There was no regrowth of treated lesions, lymph node metastasis, or distant metastasis. At the end of the follow-up, all the ablated lesions in the two groups completely disappeared or only remained scar strips. CONCLUSION: PLA is a safe and effective technique for treating multifocal PTMC, which might be an alternative technique for patients who are not eligible or are unwilling to undergo surgery.
format Online
Article
Text
id pubmed-9428260
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94282602022-09-01 The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma Zhang, Lu Zhang, Gui Ping Zhan, Wei Wei Zhou, Wei Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: The aim of this study was to evaluate the feasibility and efficacy of percutaneous laser ablation (PLA) for patients with multifocal papillary thyroid microcarcinoma (PTMC). MATERIALS AND METHODS: A cohort of patients who underwent ultrasound (US)-guided PLA for primary PTMC were enrolled in this study. The patients were divided into a multifocal PTMC (multi-PTMC) group and a unifocal PTMC (uni-PTMC) group. Before PLA, conventional US and contrast-enhanced ultrasound (CEUS) were performed to evaluate the PTMC and cervical lymph nodes. The operation time, energy, power, amount of isolation liquid, and complications during PLA were recorded. Patients were followed up at 2 days, 1 month, 3 months, and 6 months, and every 6 months after that. Volume reduction rate (VRR), local tumor recurrence, and lymph node metastasis after PLA were observed. RESULTS: The study included 12 patients with 26 PTMCs and 60 patients with 60 PTMCs. The operation time, total energy, and amount of isolation liquid in the multi-PTMC group were more than those in the uni-PTMC group (p = 0.000, 0.007, and 0.020, respectively). The mean follow-up durations in multi-PTMC and uni-PTMC groups were 19.75 ± 11.46 months (6–36 months) and 16.33 ± 10.01 months (4–40 months), with a similar VRR of the ablated lesions in the two groups. One and three cases with newly developed PTMCs were observed in the multi-PTMC group and the uni-PTMC group during follow-up, respectively. There was no regrowth of treated lesions, lymph node metastasis, or distant metastasis. At the end of the follow-up, all the ablated lesions in the two groups completely disappeared or only remained scar strips. CONCLUSION: PLA is a safe and effective technique for treating multifocal PTMC, which might be an alternative technique for patients who are not eligible or are unwilling to undergo surgery. Frontiers Media S.A. 2022-08-17 /pmc/articles/PMC9428260/ /pubmed/36060950 http://dx.doi.org/10.3389/fendo.2022.921812 Text en Copyright © 2022 Zhang, Zhang, Zhan and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zhang, Lu
Zhang, Gui Ping
Zhan, Wei Wei
Zhou, Wei
The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma
title The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma
title_full The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma
title_fullStr The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma
title_full_unstemmed The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma
title_short The feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma
title_sort feasibility and efficacy of ultrasound-guided percutaneous laser ablation for multifocal papillary thyroid microcarcinoma
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428260/
https://www.ncbi.nlm.nih.gov/pubmed/36060950
http://dx.doi.org/10.3389/fendo.2022.921812
work_keys_str_mv AT zhanglu thefeasibilityandefficacyofultrasoundguidedpercutaneouslaserablationformultifocalpapillarythyroidmicrocarcinoma
AT zhangguiping thefeasibilityandefficacyofultrasoundguidedpercutaneouslaserablationformultifocalpapillarythyroidmicrocarcinoma
AT zhanweiwei thefeasibilityandefficacyofultrasoundguidedpercutaneouslaserablationformultifocalpapillarythyroidmicrocarcinoma
AT zhouwei thefeasibilityandefficacyofultrasoundguidedpercutaneouslaserablationformultifocalpapillarythyroidmicrocarcinoma
AT zhanglu feasibilityandefficacyofultrasoundguidedpercutaneouslaserablationformultifocalpapillarythyroidmicrocarcinoma
AT zhangguiping feasibilityandefficacyofultrasoundguidedpercutaneouslaserablationformultifocalpapillarythyroidmicrocarcinoma
AT zhanweiwei feasibilityandefficacyofultrasoundguidedpercutaneouslaserablationformultifocalpapillarythyroidmicrocarcinoma
AT zhouwei feasibilityandefficacyofultrasoundguidedpercutaneouslaserablationformultifocalpapillarythyroidmicrocarcinoma